Folate therapy and in-stent restenosis after coronary stenting

Helmut Lange, Harry Suryapranata, Giuseppe De Luca, Caspar Börner, Joep Dille, Klaus Kallmayer, M. Noor Pasalary, Eberhard Scherer, Jan Henk E. Dambrink

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

BACKGROUND: Vitamin therapy to lower homocysteine levels has recently been recommended for the prevention of restenosis after coronary angioplasty. We tested the effect of a combination of folic acid, vitamin B6, and vitamin B12 (referred to as folate therapy) on the risk of angiographic restenosis after coronary-stent placement in a double-blind, multicenter trial. METHODS: A total of 636 patients who had undergone successful coronary stenting were randomly assigned to receive 1 mg of folic acid, 5 mg of vitamin B6, and 1 mg of vitamin B12 intravenously, followed by daily oral doses of 1.2 mg of folic acid, 48 mg of vitamin B 6, and 60 μg of vitamin B12 for six months, or to receive placebo. The angiographic end points (minimal luminal diameter, late loss, and restenosis rate) were assessed at six months by means of quantitative coronary angiography. RESULTS: At follow-up, the mean (±SD) minimal luminal diameter was significantly smaller in the folate group than in the placebo group (1.59±0.62 mm vs. 1.74±0.64 mm, P=0.008), and the extent of late luminal loss was greater (0.90±0.55 mm vs. 0.76±0.58 mm, P=0.004). The restenosis rate was higher in the folate group than in the placebo group (34.5 percent vs. 26.5 percent, P=0.05), and a higher percentage of patients in the folate group required repeated target-vessel revascularization (15.8 percent vs. 10.6 percent, P=0.05). Folate therapy had adverse effects on the risk of restenosis in all subgroups except for women, patients with diabetes, and patients with markedly elevated homocysteine levels (15 μmol per liter or more) at baseline. CONCLUSIONS: Contrary to previous findings, the administration of folate, vitamin B 6, and vitamin B12 after coronary stenting may increase the risk of in-stent restenosis and the need for target-vessel revascularization.

Lingua originaleInglese
pagine (da-a)2673-2681
Numero di pagine9
RivistaNew England Journal of Medicine
Volume350
Numero di pubblicazione26
DOI
Stato di pubblicazionePubblicato - 24 giu 2004
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Folate therapy and in-stent restenosis after coronary stenting'. Insieme formano una fingerprint unica.

Cita questo